News

The Economic Times reported that the company would not achieve its target through organic growth. The company would only be able to reach $2 billion in revenue through

The results of the study, carried out by experts from the University of Manchester, the University of Cambridge, Imperial College and the Institute of Psychiatry in London, found

In its ruling, the court approved agreements that created Protiva Biotherapeutics and the ongoing litigation with Protiva. The court rejected all motions raised by Protiva to block the

The FDA fast-tracks the new drug application process if a therapy can potentially address an unmet medical need for a life-threatening disease. Designation as a fast track product

“This is a major milestone in our strategy to advance our lead drug into a second indication,” said Kevin Giese, president of BioMS Medical. “MBP8298 has shown potential

The team from Queen Mary’s School of Medicine and Dentistry looked at the effect of raised homocysteine levels on heart disease and stroke. In analyzing several studies, the

UniChem, the drug wholesaling arm of the merged Alliance Boots group, recently filed an application in a Brussels commercial court against the association, which is attempting to block

In the British Medical Journal, the doctors say that new guidance from the National Institute for Health and Clinical Excellence (NICE) recommends trastuzumab (marketed as Herceptin by Genentech)

Inovelon has been approved as an adjunctive therapy in Lennox-Gastaut Syndrome (LGS) from the Committee for Medicinal Products for Human Use, the scientific body of the European Medicines